Related Experiment Video

Updated: Oct 15, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

[Relationship between cardiovascular risk profile and anti-hypertensive drug use. GEDEC (Spanish group of

A de la Sierra1, L M Ruilope, A Coca

  • 1Unidad de Hipertensión, Hospital Clínic, Barcelona. iserte@medicina.ub.es

Medicina Clinica
|August 10, 2000
PubMed

Insights

Cardiovascular risk and co-morbidities have limited impact on antihypertensive drug selection. Treatment individualization based on specific patient conditions is crucial for effective hypertension management.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Context:

  • Current hypertension guidelines prioritize absolute cardiovascular risk for treatment selection.
  • Concomitant conditions necessitate specific antihypertensive drug classes.
  • Understanding drug class utilization in relation to risk and comorbidities is essential.

Purpose:

  • To analyze the relationship between cardiovascular risk profile and co-morbid conditions on antihypertensive drug class use.
  • To evaluate how patient characteristics influence the choice of hypertension medications.

Summary:

  • Observational study of 2,850 essential hypertensive patients.
  • Diabetes, cerebrovascular, and coronary diseases influenced the use of calcium channel blockers (CCB) and ACE inhibitors.
  • Hypercholesterolemia and smoking did not affect drug class selection; diuretics and angiotensin II receptor antagonists were used more in cardiac failure.

Impact:

  • Cardiovascular risk profile shows limited influence on antihypertensive drug class choice, especially with hypercholesterolemia or cardiac failure.
  • Highlights the need for individualized hypertension treatment plans considering specific patient comorbidities.
  • Informs clinical practice regarding tailored antihypertensive therapy based on patient profiles.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...